A detailed history of Scott Marsh Financial, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Scott Marsh Financial, LLC holds 5,659 shares of NVO stock, worth $273,103. This represents 0.14% of its overall portfolio holdings.

Number of Shares
5,659
Holding current value
$273,103
% of portfolio
0.14%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

BUY
$58.08 - $81.05 $328,674 - $458,661
5,659 New
5,659 $391 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $109B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Scott Marsh Financial, LLC Portfolio

Follow Scott Marsh Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Scott Marsh Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Scott Marsh Financial, LLC with notifications on news.